Delivery Order SPE2DB20D3103-SPE2DB24FM4F5
Award Date 1/26/24
Potential Completion Date 1/29/24
Potential Value $6.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $8,804.46, is for the provision of the pharmaceutical product PULMOZYME 1 MG/ML AMPUL 2.5ML. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential total value of $999,999,999.00 and runs...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a potential value of $5,130.50 and a completion date of March 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, for a potential value of $17,002.62. This award has a completion date of March 8, 2024 and was made on March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The delivery order is part of a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML. The contract has a firm fixed price of $5,167.20 and a completion date of May 20, 2025. Amerisourcebergen Drug Corp is the prime contractor, with no subcontractors mentioned. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that the company holds with the...
- This federal contract award is a delivery order valued at $2,540.23, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a completion date of February 9, 2024. The contract type is firm fixed price. Amerisourcebergen Drug Corp is an established prime contractor providing a wide range of pharmaceutical products and medical supplies...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract has a potential value of $2,410.99 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. Amerisourcebergen Drug Corp also holds...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $24,339.01 and an ultimate completion date of February 10, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Pulmozyme 1 mg/ml ampul 2.5 ml. The contract has a ceiling value of $21,236.76 and a period of performance through April 1, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract provides for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, to support military treatment programs and facilities. The award has a ceiling value of $2,666.24 and a performance period through April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,640.92, is a delivery order for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product. The contract has a firm fixed price and an ultimate completion date of March 26, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...